ICAM1 and metabolic dysfunction-associated steatohepatitis: Hepatocyte-derived lipotoxic EVs contain DAMPs and cell adhesion molecules such as S100a11 and ICAM1, which might affect immune cell responses, thus promoting liver inflammation in NASH.